ENTRY       D10404                      Drug
NAME        Eldelumab (USAN/INN)
FORMULA     C6502H10024N1736O2026S48
EXACT_MASS  146376.131
MOL_WEIGHT  146466.6976
SEQUENCE    (Heavy chain)
            QMQLVESGGG VVQPGRSLRL SCTASGFTFS NNGMHWVRQA PGKGLEWVAV IWFDGMNKFY
            VDSVKGRFTI SRDNSKNTLY LEMNSLRAED TAIYYCAREG DGSGIYYYYG MDVWGQGTTV
            TVSSASTKGP SVFPLAPSSK STSGGTAALG CLVKDYFPEP VTVSWNSGAL TSGVHTFPAV
            LQSSGLYSLS SVVTVPSSSL GTQTYICNVN HKPSNTKVDK RVEPKSCDKT HTCPPCPAPE
            LLGGPSVFLF PPKPKDTLMI SRTPEVTCVV VDVSHEDPEV KFNWYVDGVE VHNAKTKPRE
            EQYNSTYRVV SVLTVLHQDW LNGKEYKCKV SNKALPAPIE KTISKAKGQP REPQVYTLPP
            SREEMTKNQV SLTCLVKGFY PSDIAVEWES NGQPENNYKT TPPVLDSDGS FFLYSKLTVD
            KSRWQQGNVF SCSVMHEALH NHYTQKSLSL SPG
            (Light chain)
            EIVLTQSPGT LSLSPGERAT LSCRASQSVS SSYLAWYQQK PGQAPRLLIY GASSRATGIP
            DRFSGSGSGT DFTLTISRLE PEDFAVYYCQ QYGSSPIFTF GPGTKVDIKR TVAAPSVFIF
            PPSDEQLKSG TASVVCLLNN FYPREAKVQW KVDNALQSGN SQESVTEQDS KDSTYSLSST
            LTLSKADYEK HKVYACEVTH QGLSSPVTKS FNRGEC
            (Disulfide bridge: H22-H96, H151-H207, H227-L216, H233-H'233, H236-H'236, H268-H328, H374-H432, H'22-H'96, H'151-H'207, H'227-L'216, H'268-H'328, H'374-H'432, L23-L89, L136-L196, L'23-L'89, L'136-L'196; Modified residue: H1, H'1 Q=pyroglutamic acid [CPD:C01879]; Glycosylation site: H304, H'304)
  TYPE      Peptide
EFFICACY    Anti-inflammatory, Anti-CXCL10 antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of Crohn's disease, ulcerative colitis, and other autoimmune diseases
TARGET      CXCL10 [HSA:3627] [KO:K12671]
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Chemokines
                CXCL10
                 D10404  Eldelumab (USAN/INN)
DBLINKS     CAS: 946414-98-8
            PubChem: 172232497
///
